Wrinkle in the plan: miR-34a-5p impacts chemokine signaling by modulating CXCL10/CXCL11/CXCR3-axis in CD4(+), CD8(+) T cells, and M1 macrophages

BACKGROUND: In 2016 the first-in-human phase I study of a miRNA-based cancer therapy with a liposomal mimic of microRNA-34a-5p (miR-34a-5p) was closed due to five immune related serious adverse events (SAEs) resulting in four patient deaths. For future applications of miRNA mimics in cancer therapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Hart, Martin, Nickl, Laura, Walch-Rueckheim, Barbara, Krammes, Lena, Rheinheimer, Stefanie, Diener, Caroline, Taenzer, Tanja, Kehl, Tim, Sester, Martina, Lenhof, Hans-Peter, Keller, Andreas, Meese, Eckart
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Basic Tumor Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7684812/
https://www.ncbi.nlm.nih.gov/pubmed/33229509
http://dx.doi.org/10.1136/jitc-2020-001617

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7684812/
https://www.ncbi.nlm.nih.gov/pubmed/33229509
http://dx.doi.org/10.1136/jitc-2020-001617

Ejemplares similares